Med OncologyHematology Consultants, PA Newark — Newark, Delaware

Med OncologyHematology Consultants, PA Newark is a clinical research site located in Newark, Delaware, United States 19713-7007.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Med OncologyHematology Consultants, PA Newark has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: Veru Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Med OncologyHematology Consultants, PA Newark?

Med OncologyHematology Consultants, PA Newark has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Med OncologyHematology Consultants, PA Newark conducted?

Med OncologyHematology Consultants, PA Newark has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is Med OncologyHematology Consultants, PA Newark accredited by Crixeo Health?

Med OncologyHematology Consultants, PA Newark has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Med OncologyHematology Consultants, PA Newark?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.